Congenital Cytomegalovirus Infection Clinical Trial
Official title:
A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Neonates in China
The purpose of this study is to assess the risk of congenital cytomegalovirus (cCMV) infection in newborns born to seropositive women.
This study will be conducted at several Maternal and Child Health Hospitals (MCHHs) in China and the research activities will be integrated with routine medical services during pregnancy at the study sites.The investigators will build a perspective cohort study enrolling ~8000 pregnant women elder than 18 and following up their newborns at specific MCHHs.As a first step, The investigators will work with these hospitals to recruit the subjects. After being informed, the participants' remaining blood and urine samples (after their medical examinations) at their early, medium and late stages of pregnancy will be collected , and their newborns' urine and saliva samples will be collected after delivery. The aim of this study is to enroll 5000 series mother-newborns. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01923636 -
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
|
N/A | |
| Recruiting |
NCT03973359 -
Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy
|
N/A | |
| Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
| Completed |
NCT02139423 -
Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
|
N/A | |
| Withdrawn |
NCT02594566 -
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
|
Phase 1 | |
| Completed |
NCT02351102 -
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05170269 -
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
|
Phase 3 | |
| Not yet recruiting |
NCT06118515 -
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
|
Phase 1 | |
| Completed |
NCT02782988 -
Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
|
||
| Terminated |
NCT01655212 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
|
Phase 3 | |
| Completed |
NCT02710864 -
A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
|
||
| Completed |
NCT05754879 -
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
|
||
| Terminated |
NCT03301415 -
Asymptomatic Congenital CMV Treatment
|
Phase 2 | |
| Completed |
NCT01376778 -
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
|
Phase 3 |